risks of using semaglutide Recent study at UC Irvine found that medication may benefit 93 million U.S. adults GLP-1 drugs such as semaglutide

In 2022, India ranked third on the list of countries with the most adults with obesity

By 12 months post-stop, most patients have returned to within 10 to 20 percent of their starting weight

Traditional oral forms tend to have lower bioavailability because glutathione is broken down by enzymes in the digestive tract before reaching the bloodstream

Total knee arthroplasty with or without prior bariatric surgery: a systematic review and meta-analysis

Navigating medication and prescriptions can be more accessible than ever

Recent studies have shown that GLP-/GIP dual agonists also have significant lipid-regulating effects